By Gregg A. Masters, MPH We’re here in the ‘city by the bay’ for the 31st annual assembly of biotech and pharma peeps and the money they seek from the venture capital world. Not exactly my tribe, but my interest was sparked by the generous ‘non profit track’ with many nameplate integrated delivery systems in …
Author Archives: Admin
More or Less Confusion in ACO World: Who Really ‘Certifies’ ACOs?
By Gregg A. Masters, MPH The ‘signal to noise’ discernment premium went up a notch recently with the following tweet: @NCQA Read more about newly recognized ACO @KelseySeybold and their commitment to quality and value in the Houston Chronicle http://ow.ly/g6vzl 7:39 AM – 14 Dec 12 And with that breaking news announcement (Kelsey Seybold is …
Continue reading “More or Less Confusion in ACO World: Who Really ‘Certifies’ ACOs?”
Standing Up the ACO: Lessons from South Park?
By Gregg A. Masters, MPH On Sunday I was chatting with a friend in the biz and the conversation turned to ACOs, wherein he whimsically laughed and then relayed a story from a recent California Medical Association (CMA) sponsored event on health reform, the future of medicine and Accountable Care Organizations, wherein one of the …
Continue reading “Standing Up the ACO: Lessons from South Park?”
New England Healthcare Institute (NEHI) ACO Innovation Summit
November 27th, 2012 [Editor’s note: portions of broadcast present with low audio]. NEHI Summit Explores Innovations In the Emerging ACO Landscape The opportunities – and the challenges – presented by the rapid movement towards Accountable Care Organizations were the subject of a recent NEHI summit that drew perspectives from across health care: “I think ACOs …
Continue reading “New England Healthcare Institute (NEHI) ACO Innovation Summit”
Accountable Care: It’s Growth, Complexity, Prevalence and Promise?
By Gregg A. Masters, MPH From Leavitt Partners. a webinar held on November 8th, 2012. The focus is on ACOs, and represents an update post elections from their previous reporting here.
A/C/O: ‘Another Compromised Organization’ or ‘A Coordinated Orchestra?’
By Gregg A. Masters, MPH Last Friday I moderated the HealthIT social media focused tweetchat tagged ‘#HITsm’, see context piece here, and transcript here. The theme centered on the value or centrality of HealthIT to ACO success. The conversation was lively (for additional context, ACO surprise provides metrics on dispersion and penetration into Medicare and commercial markets), and …
Continue reading “A/C/O: ‘Another Compromised Organization’ or ‘A Coordinated Orchestra?’”
None of the Ransomed Ever Knew How Deep Were the Waters Crossed
By Gregg A. Masters, MPH Ah yes, those ‘white waters’ of health reform or more aptly put ‘transformation’ (you know, the triple aim thingy). As more has been revealed, I offer a quasi ‘mea culpa’ of sorts… Light years ago, or so it seems, as I began at least the blogging portion of my social …
Continue reading “None of the Ransomed Ever Knew How Deep Were the Waters Crossed”
ACOs: Here, There, Everywhere? Or Are We Quibbling at the Edges?
By Vince Kuraitis, JD, MBA A recent analysis of the ACO market by Oliver Wyman market suggests we’re well on our way toward being “there”. My personal take on this report: Provocative, fresh, thoughtful, well reasoned, expansive — albeit a bit of a stretch. However, I suspect many others will describe it as: Speculative, harebrained, unsupported, overly …
Continue reading “ACOs: Here, There, Everywhere? Or Are We Quibbling at the Edges?”
ACOs, Oncology and the Future of Better Cancer Care
By Gregg A. Masters, MPH As originally posted at JustOncology. The best business model for oncology care is not yet obvious to me. But it is crystal clear that innovative new models are being hatched before our eyes.. via Oncology Times Since CMS (via HHS) issued the final rule addressing ACO provisions and specifically ‘excluded’ oncologists …
Continue reading “ACOs, Oncology and the Future of Better Cancer Care”
The ACO Surprise
By Gregg A. Masters, MPH Timing can be everything at times, no? Just after completing the post: ‘From “Unicorns to Multicorns” ACOs Morphing Below Radar‘, I received information from Oliver Wyman, a Marsh McLennan Company, previewing a study which documents (at least for some) ‘unexpected’ results in the world of ACO penetration. For background market …
acowatch.me 